Post-Exposure Prophylaxis against HBV and HIV Infection in Health Care Workers

Azar Hadadi, Mojgan Karbakhsh, Mehrnaz Rasoolinejad, Mahboobeh Haji Abdolbaghi, Nahid Hadadi, Shirin Afhami, Negin Esmaeelpour-Bazzaz

.
Internal Medicine Ward, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

DOI: 10.4236/aid.2013.33028                

Abstract

Healthcare Workers (HCWs) are constantly at risk of exposure to viral infections such as hepatitis B virus (HBV), human immune deficiency virus (HIV) and hepatitis C virus (HCV). We aim at demonstrating the results of a three-year period of a surveillance program in Iran with the prospective follow-up of HCWs exposed to blood-borne viruses. HCWs who had experienced an occupational exposure to HBV, HCV or HIV from September 2005 to 2008 were enrolled in the study. Age, gender, route of exposure, type of fluid, type of virus, job, department, working shift, work experience, wearing gloves when exposed, history of HBV vaccination and the serum level of anti HBs antibody were recorded for all participants through an individual interview. Serum samples were taken from both HCWs and the sources of exposure and were tested by enzyme linked immunosorbent assay (ELISA). The data were gathered through questionnaires completed by a nurse under the supervision of a specialist of infectious diseases. In this study, 100 HCWs who were occupationally exposed to HIV, HCV or HBV were included. Most exposures had occurred among nurses (35%), followed by residents (29%), interns (18%), housekeepers (7%), the lab staff (6%), and specialists (5%). Most of the exposures had occurred in emergency (21%) and surgical (20%) wards. The most common route of exposure was percutaneous injuries (77%) and the most common cases had contacted with needles and angiocaths (71.1%) during injection or opening vein routes (21%). Establishing a surveillance system for registering the occurrence of occupational hazardous exposures, performing prophylactic measures and following up the exposed is a necessity in hospitals so that the number of exposures and occupational diseases among the HCWs can be decreased.

Keywords

Post-Exposure Prophylaxis; HBV Infection; HIV Infection; Health Care Workers

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	E. N. Daryani, “Viral and Autoimmune Hepatitis,” Taeb, Tehran, 1991, pp. 77-153.
[2]	Centers for Disease Control, “Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis,” Morbidity and Mortality Weekly Report, Vol. 29, No. 50(RR-11), 2001, pp. 1-42. www.cdc.gov/mmwr/preview/mmwrhtml/rr5011a1.htm
[3]	A. K. Sepkowitz, “Nosocomial Hepatitis and Other Infections Transmitted by Blood and Blood Products,” In: G. L. Mandell, J. E. Bennett and R. Dolin, Eds., Principles and Practice of Infectious Diseases, 6th Edition, Churchill Livingstone, Philadelphia, 2005, pp. 3381-3405.
[4]	I. V. Bassett, K. A. Freedberg and R. P. Walensky, “Two Drugs or Three? Balancing Efficacy, Toxicity, and Resistance in Postexposure Prophylaxis for Occupational Exposure to HIV,” Clinical Infectious Diseases, Vol. 39, No. 3, 2004, pp. 395-401. doi:10.1086/422459
[5]	A. Pruss-Ustun, E. Rapiti and Y. Hutin, “Estimation of the Global Burden of Disease Attributable to Contaminated Sharps Injuries among Health-Care Workers,” American Journal of Industrial Medicine, Vol. 48, No. 6, 2005, pp. 482-490. doi:10.1002/ajim.20230
[6]	A. Hadadi, S. Afhami, M. Karbakhsh and N. Esmailpour, “Occupational Exposure to Body Fluids among Healthcare Workers: A Report from Iran,” Singapore Medical Journal, Vol. 49, No. 6, 2008, pp. 492-496.
[7]	W. B. Hsieh, N. C. Chiu, C. M. Lee and F. Y. Huang, “Occupational Blood and Infectious Body Fluid Exposures in a Teaching Hospital: A Three-Year Review,” Journal of Microbiology, Immunology and Infection, Vol. 39, No. 4, 2006, pp. 321-327.
[8]	S. Jahan, “Epidemiology of Needlestick Injuries among Health Care Workers in a Secondary Care Hospital in Saudi Arabia,” Annals of Saudi Medicine, Vol. 25, No. 3, 2005, pp. 233-238.
[9]	Z. A. Memish, M. Almuneef and J. Dillon, “Epidemiology of Needlestick and Sharps Injuries in a Tertiary Care Center in Saudi Arabia,” American Journal of Infection Control, Vol. 30, No. 4, 2002, pp. 234-241. doi:10.1067/mic.2002.118841
[10]	A. Azap, O. Ergonul, K. O. Memikoglu, et al., “Occupational Exposure to Blood and Body Fluids among Health Care Workers in Ankara, Turkey,” American Journal of Infection Control, Vol. 33, No. 1, 2005, pp. 48-52. doi:10.1016/j.ajic.2004.08.004
[11]	W. Phipps, H. H. Wang, M. Yang, J. Burgess, L. Pellico, C. W. Watkins, G. P. He and A. Williams, “Risk of Medical Sharps Injuries among Chinese Nurses,” American Journal of Infection Control, Vol. 30, No. 5, 2002, pp. 277-282. doi:10.1067/mic.2002.122435
[12]	M. Talaat, A. Kandeel, W. El-Shoubary, C. Bodenschatz, I. Khairy, S. Oun and F. J. Mahoney, “Occupational Exposure to Needle Stick Injuries and Hepatitis B Vaccination Coverage among Health Care Workers in Egypt,” American Journal of Infection Control, Vol. 31, No. 8, 2003, pp. 469-474. doi:10.1016/j.ajic.2003.03.003
[13]	E. M. Jochimsen, “Failures of Zidovudine Postexposure Prophylaxis,” American Journal of Medicine, Vol. 102, No. 5B, 1997, pp. 52-55.
[14]	S. Tomkins and F. Ncube, “Occupationally Acquired HIV: International Reports to December 2002,” Eurosurveillance, Vol. 10, No. 3, 2005, Article ID: E050310.2.
[15]	Centers for Disease Control and Prevention, “Provisional Public Health Service Recommendation for Chemoprophylaxis after Occupational Exposure to HIV,” Morbidity and Mortality Weekly Report, Vol. 45, No. 22, 1996, pp. 468-480. http://www.cdc.gov/mmwr/preview/mmwrhtml/00042200.htm
[16]	A. N. Do, C. A. Ciesielski, R. P. Metler, T. A. Hammett, J. Li and P. L. Fleming, “Occupationally Acquired Human Immunodeficiency Virus (HIV) Infection: National Case Surveillance Data during 20 Years of the HIV Epidemic in the United States,” Infection Control and Hospital Epidemiology, Vol. 24, No. 2, 2003, pp. 86-96. doi:10.1086/502178
[17]	D. M. Cardo, D. H. Culver, C. A. Ciesielski, P. U. Srivastava, R. Marcus, D. Abiteboul, J. Heptonstall, G. Ippolito, F. Lot, P. S. McKibben and D. M. Bell, for Centers for Disease Control and Prevention Needlestick Surveillance Group, “A Case-Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure,” New England Journal of Medicine, Vol. 337, No. 21, 1997, pp. 1485-1490. doi:10.1056/NEJM199711203372101
[18]	J. I. Tokars, R. Marcus, D. H. Culver, C. A. Schable, P. S. McKibben, C. I. Bandea and D. M. Bell, for The CDC Cooperative Needlestick Surveillance Group, “Surveillance of HIV Infection and Zidovudine Use among Health Care Workers after Occupational Exposure to HIV-Infected Blood,” Annals of Internal Medicine, Vol. 118, No. 12, 1993, pp. 913-919. doi:10.7326/0003-4819-118-12-199306150-00001
[19]	S. A. Wang, A. L. Panlilio, P. A. Doi, A. D. White, M. Stek Jr. and A. Saah, “Experience of Healthcare Workers Taking Postexposure Prophylaxis after Occupational HIV Exposures: Findings of the HIV Postexposure Prophylaxis Registry,” Infection Control and Hospital Epidemiology, Vol. 21, No. 12, 2000, pp. 780-785. doi:10.1086/501736
[20]	A. Mehta, C. Rodrigues, S. Ghag, P. Bavi, S. Shenai and F. Dastur, “Needlestick Injuries in a Tertiary Care Centre in Mumbai, India,” Journal of Hospital Infection, Vol. 60, No. 4, 2005, pp. 368-373. doi:10.1016/j.jhin.2004.12.015